ISRCTN17228973
Terminated
未知
Efficacy of text messaging-based aftercare following inpatient addiction treatment - DASA (Drug Alcohol SMS Aftercare): a randomised controlled trial
Swiss Research Institute for Public Health and Addiction ISGF0 sites554 target enrollmentJuly 12, 2017
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Relapse prevention for former patients who completed addiction treatment successfully
- Sponsor
- Swiss Research Institute for Public Health and Addiction ISGF
- Enrollment
- 554
- Status
- Terminated
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Age \>\=18 years
- •2\. Residential treatment will presumably be finished within one week
- •3\. Main problem substances at beginning of treatment: opioids, cocaine, cannabis or alcohol
- •4\. Personally set goals: abstinence (re. illegal substances and alcohol) or controlled drinking respectively
- •5\. Owning a mobile phone
Exclusion Criteria
- •Cognitive or linguistic deficits or health impairments which impede following the SMS dialogue
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Can supportive text messaging post-detox boost treatment outcomes following inpatient alcohol and other drug withdrawal?AddictionAlcohol problemsDrug problemsMental healthMental Health - AddictionACTRN12616000036415Turning Point, part of Eastern Health100
Not yet recruiting
Not Applicable
Clinical Application of Text Messaging for Anxiety and DepressioAnxietyDepressionMental Health - AnxietyMental Health - DepressionACTRN12621000410853Australian Catholic University450
Completed
Not Applicable
Study on effectiveness of text message intervention through a smartphone application targeting shopping mall walkerswalking (steps)health conditionswell-beingJPRN-UMIN000049383Chiba University92,184
Active, not recruiting
Phase 4
Messaging Service for Patients with Type 2 Diabetes to support Insulin TitratioHealth Condition 1: E119- Type 2 diabetes mellitus without complicationsCTRI/2021/05/033506Roche Diabetes Care India Pvt Ltd
Completed
Not Applicable
Analysis of a messaging service to support patients with type 2 diabetes on basal insulin therapyType 2 diabetes mellitusNutritional, Metabolic, EndocrineISRCTN11911344Roche Diabetes Care GmbH30